Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Receivables
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Receivables of -$5.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2020-03-16
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for the quarter ending 2019-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for the quarter ending 2019-09-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for the quarter ending 2018-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for fiscal 2019 was -$5.00M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for fiscal 2018 was -$12.50M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for fiscal 2017 was -$1.00M, a 200.00% decline from fiscal 2016.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in receivables for fiscal 2016 was $1.00M.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | -$5.00M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$5.00M 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | -$5.00M 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | -$6.25M derived: sum of 3 quarters · filed 2020-03-16 | -$12.50M 10-K · filed 2020-03-16 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$6.25M derived: sum of 2 quarters · filed 2019-11-07 | -$12.50M 10-Q · filed 2019-11-07 | -$13.00M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$12.50M 10-Q · filed 2019-08-08 | -$13.00M derived: sum of 3 quarters · filed 2019-08-08 | -$12.50M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$6.25M 10-Q · filed 2019-05-09 | -$6.75M derived: sum of 2 quarters · filed 2019-05-09 | -$6.25M derived: sum of 3 quarters · filed 2019-05-09 | -$6.25M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $0.00 derived: sum of 2 quarters · filed 2019-03-12 | $0.00 derived: sum of 3 quarters · filed 2019-03-12 | -$1.00M 10-K · filed 2019-03-12 |
| 2017-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $500.00K derived: sum of 2 quarters · filed 2018-11-08 | -$500.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$1.00M 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | -$1.00M 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $1.00M 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |